USR Unitat Transversal de Recerca

avatar_grups_recerca.png

Publications

Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019

A. MORENO-MINGORANCE, P. ESPINAL, V. RODRIGUEZ, L. GOTERRIS, A. FABREGA, J. SERRA-PLADEVALL, M. BARBERA, M. ALBERNY, H. MARTIN-GONZALEZ, T. CORNEJO-SANCHEZ, M. ARMAS, A. MIR-CROS, A. RAVENTOS, B. VINADO, T. PUMAROLA, M. LARROSA and J. GONZALEZ-LOPEZ
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2021 Sep 1; . doi:10.1016/j.ijantimicag.2021.106378; PMID:34157402

  • Any: 01/09/2021
  • FI: 15.441
  • Article

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

E. GARCIA-ESCOBAR, S. VALDES, F. SORIGUER, J. VENDRELL, I. URRUTIA-ETXEBARRIA, C. MALDONADO-ARAQUE, E. ORTEGA, P. OCON, E. MONTANYA, E. MENENDEZ, A. LAGO-SAMPEDRO, T. GONZALEZ-FRUTOS, R. GOMIS, A. GODAY, S. GARCIA-SERRANO, J. GALAN-GARCIA, C. CASTELL, E. BORDIU, R. BADIA, G. AGUILERA-VENEGAS, J. GIRBES, S. GAZTAMBIDE, E. DELGADO, F. CHAVES, L. CASTANO, A. CALLE-PASCUAL, G. ROJO-MARTINEZ and J. FRANCH-NADAL
Scientific Reports. 2021 Aug 12; . doi:10.1038/s41598-021-95546-x; PMID:34385479

  • Any: 12/08/2021
  • FI: 4.996
  • Article

SIGMA Consortium: A new era of collaboration to study the safety and effectiveness of medical interventions

J. KUIPER, C. FRANZONI, V. EHRENSTEIN, R. GINI, U. HAUG, N. MOORE, C. DROZ-PERROTEAU, B. BOLIBAR, M. ARAGON, J. HALLAS, T. MACDONALD, M. STURKENBOOM, O. KLUNGEL, S. PEREZ-GUTTHANN and R. HERINGS
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021 Aug 1;

  • Any: 01/08/2021
  • FI: 2.732
  • Article

Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review

S. SEIDU, S. KUNUTSOR, X. COS and K. KHUNTI
Primary Care Diabetes. 2021 Aug 1; . doi:10.1016/j.pcd.2021.05.011; PMID:34083122

  • Any: 01/08/2021
  • FI: 2.567
  • Article

Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

K. KHUNTI, M. KOSIBOROD, D. KIM, S. KOHSAKA, C. LAM, S. GOH, C. CHIANG, J. SHAW, M. CAVENDER, N. TANGRI, J. FRANCH-NADAL, R. HOLL, M. JORGENSEN, A. NORHAMMAR, J. ERIKSSON, F. ZACCARDI, A. KARASIK, D. MAGLIANO, M. THURESSON, H. CHEN, E. WITTBRODT, J. BODEGARD, F. SURMONT and P. FENICI
Cardiovascular Diabetology. 2021 Jul 31; . doi:10.1186/s12933-021-01345-z; PMID:34332558

  • Any: 31/07/2021
  • FI: 8.949
  • Article

Board of Trustees

Collaborators

Accreditations